Home » MERCK IN CANCER RESEARCH DEAL WITH AVEO
MERCK IN CANCER RESEARCH DEAL WITH AVEO
Pharmaceutical firm Merck & Co. is joining with privately-held Aveo Pharmaceuticals
Inc. to develop certain targeted cancer therapies, Aveo said Wednesday. The
company did not provide financial details in a news release. The agreement,
Merck's second with Aveo, covers the use of Aveo technology to identify patient
groups likely to respond to a number of experimental cancer drugs Merck is currently
developing.
Forbes
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May